drugset / Trial / NCT06560762
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NaSequentialOpen-labelTreatment
Summary
A Phase 1, Open label, Multiple Ascending Dose Study to Assess Safety and Tolerability of STM-01 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Timeline
- Start
- 2025-03-03
- Primary completion
- 2025-12-15
- Completion
- 2025-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STM01 | Unknown | 1e+08 cells | — |
| Subject | STM01 | Unknown | 2e+08 cells | — |